Santhera Pharmaceuticals Holding AG (OTCPK:SPHDF)
$ 11.7 0 (0%) Market Cap: 121.08 Mil Enterprise Value: 162.23 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 19/100

Full Year 2022 Santhera Pharmaceuticals Holding AG Earnings Call Transcript

Apr 27, 2023 / 12:30PM GMT
Release Date Price: $6.8
Operator

Ladies and gentlemen, welcome to the Santhera Pharmaceuticals 2022 financial results and corporate update conference call. I am Sandra, the Chorus Call operator. I would like to remind you that all participants will be in listen-only mode, and the conference is being recorded. The presentation will be followed by a Q&A session. (Operator Instructions)

This conference call may contain certain forward-looking statements based on the current assumptions and forecasts made by Santhera Pharmaceuticals. Such statements involve certain risks, uncertainties, and other factors, which could cause the actual results, financial condition, performance, and achievement of Santhera Pharmaceuticals to be materially different from those expressed or implied by such statements.

These factors include those discussed and the comprehensive risk factor disclosure of the company's website at www.santhera.com. Santhera disclaims any obligation to update any forward-looking statements. The conference may be downloaded on Santhera's website

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot